These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33717733)

  • 1. Role of Oxytocin in the Pathogenesis and Modulation of Borderline Personality Disorder: A Review.
    Jawad MY; Ahmad B; Hashmi AM
    Cureus; 2021 Feb; 13(2):e13190. PubMed ID: 33717733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of oxytocin in borderline personality disorder.
    Brüne M
    Br J Clin Psychol; 2016 Sep; 55(3):287-304. PubMed ID: 26616386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of interpersonal trust in borderline personality disorder by intranasal oxytocin and childhood trauma.
    Ebert A; Kolb M; Heller J; Edel MA; Roser P; Brüne M
    Soc Neurosci; 2013; 8(4):305-13. PubMed ID: 23802121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced vagal activity in borderline personality disorder is unaffected by intranasal oxytocin administration, but predicted by the interaction between childhood trauma and attachment insecurity.
    Back SN; Schmitz M; Koenig J; Zettl M; Kleindienst N; Herpertz SC; Bertsch K
    J Neural Transm (Vienna); 2022 Apr; 129(4):409-419. PubMed ID: 35275249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of oxytocin on social cognition in borderline personality disorder.
    Servan A; Brunelin J; Poulet E
    Encephale; 2018 Feb; 44(1):46-51. PubMed ID: 29273344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased oxytocin plasma levels and oxytocin receptor expression in borderline personality disorder.
    Carrasco JL; Buenache E; MacDowell KS; De la Vega I; López-Villatoro JM; Moreno B; Díaz-Marsá M; Leza JC
    Acta Psychiatr Scand; 2020 Oct; 142(4):319-325. PubMed ID: 32740913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intranasal oxytocin administration on empathy and approach motivation in women with borderline personality disorder: a randomized controlled trial.
    Domes G; Ower N; von Dawans B; Spengler FB; Dziobek I; Bohus M; Matthies S; Philipsen A; Heinrichs M
    Transl Psychiatry; 2019 Dec; 9(1):328. PubMed ID: 31801937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions.
    Amad A; Thomas P; Perez-Rodriguez MM
    Curr Pharm Des; 2015; 21(23):3311-6. PubMed ID: 26088114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower Oxytocin Plasma Levels in Borderline Patients with Unresolved Attachment Representations.
    Jobst A; Padberg F; Mauer MC; Daltrozzo T; Bauriedl-Schmidt C; Sabass L; Sarubin N; Falkai P; Renneberg B; Zill P; Gander M; Buchheim A
    Front Hum Neurosci; 2016; 10():125. PubMed ID: 27064696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent effects of oxytocin on (para-)limbic reactivity to emotional and neutral scenes in females with and without borderline personality disorder.
    Lischke A; Herpertz SC; Berger C; Domes G; Gamer M
    Soc Cogn Affect Neurosci; 2017 Nov; 12(11):1783-1792. PubMed ID: 29036358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring nonverbal synchrony in borderline personality disorder: A double-blind placebo-controlled study using oxytocin.
    Ramseyer F; Ebert A; Roser P; Edel MA; Tschacher W; Brüne M
    Br J Clin Psychol; 2020 Jun; 59(2):186-207. PubMed ID: 31774581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin influences avoidant reactions to social threat in adults with borderline personality disorder.
    Brüne M; Ebert A; Kolb M; Tas C; Edel MA; Roser P
    Hum Psychopharmacol; 2013 Nov; 28(6):552-61. PubMed ID: 23950057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Perspective on the Pathophysiology of Borderline Personality Disorder: A Model of the Role of Oxytocin.
    Herpertz SC; Bertsch K
    Am J Psychiatry; 2015 Sep; 172(9):840-51. PubMed ID: 26324303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin can hinder trust and cooperation in borderline personality disorder.
    Bartz J; Simeon D; Hamilton H; Kim S; Crystal S; Braun A; Vicens V; Hollander E
    Soc Cogn Affect Neurosci; 2011 Oct; 6(5):556-63. PubMed ID: 21115541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurobiology of social deficits in female patients with borderline personality disorder: The importance of oxytocin.
    Bomann AC; Jørgensen MB; Bo S; Nielsen M; Gede LB; Elfving B; Simonsen E
    Personal Ment Health; 2017 May; 11(2):91-100. PubMed ID: 28397403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart and brain: Cortical representation of cardiac signals is disturbed in borderline personality disorder, but unaffected by oxytocin administration.
    Schmitz M; Müller LE; Schulz A; Kleindienst N; Herpertz SC; Bertsch K
    J Affect Disord; 2020 Mar; 264():24-28. PubMed ID: 31846808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Neurobiology of Borderline Personality Disorder.
    Perez-Rodriguez MM; Bulbena-Cabré A; Bassir Nia A; Zipursky G; Goodman M; New AS
    Psychiatr Clin North Am; 2018 Dec; 41(4):633-650. PubMed ID: 30447729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between the Oxytocin Level and Rejection Sensitivity, Childhood Traumas, and Attachment Styles in Borderline Personality Disorder.
    Kartal F; Uğur K; Mete B; Demirkol ME; Tamam L
    Psychiatry Investig; 2022 Mar; 19(3):239-246. PubMed ID: 35330564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced plasma oxytocin levels in female patients with borderline personality disorder.
    Bertsch K; Schmidinger I; Neumann ID; Herpertz SC
    Horm Behav; 2013 Mar; 63(3):424-9. PubMed ID: 23201337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder.
    Bertsch K; Gamer M; Schmidt B; Schmidinger I; Walther S; Kästel T; Schnell K; Büchel C; Domes G; Herpertz SC
    Am J Psychiatry; 2013 Oct; 170(10):1169-77. PubMed ID: 23982273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.